Exosome Diagnostics is classified as operating in the Legal Services industry, NAICS Code 5411.
Investor Activity
Exosome Diagnostics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
July 6, 2017
43
100%
$30 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Exosome Diagnostics is developing and marketing.
Exosome Diagnostics doesn't have any recent trademark applications, indicating Exosome Diagnostics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
EXOSOMEDX Urine collection kits; plasma collection kits; medical diagnostics instruments and apparatus for the analysis of bodily fluids
04/04/2018
EXOLUTION Medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the fields of cancer, neurodegenerative diseases, Huntington's disease, Parkinson's disease, and Alzheimer's disease; medical diagnostic testing, monitoring and reporting services; liquid biopsy testing for medical purposes
04/04/2018
SHAHKY Medical diagnostics instruments and apparatus for the analysis of bodily fluids
04/04/2018
See all trademarks and details in the Full Report.
Market Share of Exosome Diagnostics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Exosome Diagnostics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Exosome Diagnostics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Exosome Diagnostics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.